Sie sind hier: Startseite International Proteolysis Society …

International Proteolysis Society (IPS) Symposium: Proteases in SARS-CoV2 Infections

Joint ProtPath and IPS Symposium:                                                            logo

Proteases in SARS-CoV2  Infections

January 20th, 2022

17:00 (CET), 8:00 am (PDT), 9:00 am (MST), 11:00 am (EST)

online via Zoom

The Symposium is free of charge. Register here by January 10th, 2022


confirmed speakers:

Rolf Hilgenfeld, University of Lübeck, Germany


The SARS COV-2 main protease -  inhibitors, structures and mutations



17:00-17:45 CET, 8:00-8:45 PDT 

Wioletta Rut, the Wrocław University of Technology, Poland

(Post-doctoral fellow in the lab of Marcin Drag)

SARS-CoV-2 Mpro and PLpro as attractive targets in COVID-19 therapy



18:00-18:20 CET, 9:00-9:20 PDT

Joanne Lemieux, University of Alberta, Canada


Antiviral drug development targeting the SARS-CoV-2 main protease



18:30-18:50 CET, 9:30-9:50 PDT

Isabel Pablos, University of British Columbia, Canada

 (Post-doctoral fellow in the lab of Chris Overall)


SARS-CoV-2 main protease 3CLpro cleaves key cellular substrates involved in translation, proliferation and antiviral autophagy


19:00 - 19:20 CET, 10:00-10:20 PDT

James W. Janetka, Washington University, Medical Campus, USA


Multi-effect protease inhibitors block SARS-CoV-2 viral entry and COVID-19 pathogenesis



19:30-19:50 CET, 10:30-10:50 PDT



Ruth Geiss-Friedlander, Albert-Ludwigs-University Freiburg, Freiburg, Germany

IPS Vice President



Anthony O’Donoghue, University of California, San Diego, USA

IPS President


The Symposium is free of charge. Please register here by January 10th, 2022. Zoom link to the webinar will be distributed to the participants some days before.